- Home
- MGLD vs CPIX Comparison
MGLD vs CPIX Comparison
Compare MGLD & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGLD
- CPIX
- Stock Information
- Founded
- MGLD 1996
- CPIX 1999
- Country
- MGLD United States
- CPIX United States
- Employees
- MGLD N/A
- CPIX N/A
- Industry
- MGLD Finance/Investors Services
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- MGLD Finance
- CPIX Health Care
- Exchange
- MGLD Nasdaq
- CPIX Nasdaq
- Market Cap
- MGLD 44.8M
- CPIX 48.5M
- IPO Year
- MGLD N/A
- CPIX 2009
- Fundamental
- Price
- MGLD $1.07
- CPIX $3.38
- Analyst Decision
- MGLD
- CPIX
- Analyst Count
- MGLD 0
- CPIX 0
- Target Price
- MGLD N/A
- CPIX N/A
- AVG Volume (30 Days)
- MGLD 15.1K
- CPIX 32.1K
- Earning Date
- MGLD 11-07-2025
- CPIX 11-06-2025
- Dividend Yield
- MGLD N/A
- CPIX N/A
- EPS Growth
- MGLD N/A
- CPIX N/A
- EPS
- MGLD N/A
- CPIX N/A
- Revenue
- MGLD $31,205,000.00
- CPIX $42,071,813.00
- Revenue This Year
- MGLD N/A
- CPIX N/A
- Revenue Next Year
- MGLD N/A
- CPIX N/A
- P/E Ratio
- MGLD N/A
- CPIX N/A
- Revenue Growth
- MGLD N/A
- CPIX 11.34
- 52 Week Low
- MGLD $0.64
- CPIX $1.04
- 52 Week High
- MGLD $2.10
- CPIX $7.25
- Technical
- Relative Strength Index (RSI)
- MGLD 59.78
- CPIX 49.09
- Support Level
- MGLD $1.01
- CPIX $3.26
- Resistance Level
- MGLD $1.15
- CPIX $3.57
- Average True Range (ATR)
- MGLD 0.08
- CPIX 0.20
- MACD
- MGLD 0.01
- CPIX 0.01
- Stochastic Oscillator
- MGLD 75.00
- CPIX 29.55
About MGLD The Marygold Companies Inc.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.